Counseling Points - September 2007 - (Page 2)

Faculty: Carolyn Baird, MEd, MBA, RN-BC, CARN-AP, CCDP-D Therapist, Isaly Counseling Associates, Pittsburgh, PA President, International Nurses Society on Addictions (IntNSA) William J. Lorman, PhD, MSN, PsyNP, CARN-AP Clinical Director, Livengrin Foundation, Bensalem, PA Assistant Professor, Graduate School of Nursing, Drexel University, Philadelphia, PA Adjunct Assistant Professor, Graduate Program, College of Education, Rider University, Lawrenceville, NJ Kathleen Thompson-Gargano, RN, ADN Research Nurse in Addiction at Yale Research Center, New Haven, CT Co-founder, The National Alliance of Advocates for Buprenorphine Treatment (NAABT.org) Faculty Disclosure Statements: Carolyn Baird has no potential conflicts to disclose. William Lorman is on the Speaker’s Bureaus for Bristol-Myers Squibb, Otsuka America Pharmaceutical, Pfizer Inc., and Reckitt Benckiser Pharmaceuticals Inc. Kathleen Thompson-Gargano is an occasional speaker for Reckitt Benckiser Pharmaceuticals Inc., and co-founder of The National Alliance of Advocates for Buprenorphine Treatment (NAABT.org). Publishing Information: Publishers Joseph J. D’Onofrio Frank M. Marino David B. Zied Delaware Media Group 66 South Maple Avenue Ridgewood, NJ 07450 201-612-7676 Fax: 201-612-8282 www.delmedgroup.com Writer Linda Peckel Art Director James Ticchio ©2007, Delaware Media Group, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this publication are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the International Nurses Society on Addictions (IntNSA), Wisconsin Nurses Association, Pennsylvania Certification Board, Reckitt Benckiser Pharmaceuticals Inc., and Delaware Media Group. Counseling Points™ Enhancing Patient Care and Providing Caregiver Support Continuing Education Information Target Audience This educational activity is designed to meet the needs of nurses working with patients with confirmed opioid addictions, as well as other nurses who may have contact with individuals at risk for opioid misuse or dependence. Learning Objectives Upon completion of this educational activity, the participant should be able to: • Assess patients for opioid dependency and recognize those who may be at risk of developing a dependency • Explain the pharmacology and side effects of methadone and buprenorphine • Educate the patient about how to prepare for and what to expect from induction therapy • Know the steps to conducting the required medical visits during induction • Understand the role of counseling in medication-assisted treatment for opioid addiction Continuing Education Credit This continuing nursing education activity was approved by the Wisconsin Nurses Association Education Approval Program committee, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This activity has been approved for 1 contact hour. This program expires October 1, 2009. This educational program has been approved by the Pennsylvania Certification Board for 1 hour of substance abuse continuing education credit. Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The International Nurses Society on Addictions (IntNSA), Wisconsin Nurses Association, Pennsylvania Certification Board, Reckitt Benckiser Pharmaceuticals Inc., and Delaware Media Group do not recommend the use of any agent outside of the labeled indications.The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the International Nurses Society on Addictions (IntNSA), Wisconsin Nurses Association, Pennsylvania Certification Board, Reckitt Benckiser Pharmaceuticals Inc., or Delaware Media Group. Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities. This information should not be used to replace sound medical judgment, nor does it represent a recommendation or endorsement by Reckitt Benckiser Pharmaceuticals Inc. 2 COUNSELING POINTS™ http://NAABT.org http://NAABT.org http://www.delmedgroup.com

Table of Contents Feed for the Digital Edition of Counseling Points - September 2007

Welcome Office-Based Medication-Assisted Treatment of Opioid Dependence Summary Continuing Education Posttest Postest Answer and Program Evaluation Form

Counseling Points - September 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.